银屑病药物有意与无意不依从:用药信念与习惯强度的作用
潜在剖面分析支持三组模型,最强用药担忧组与有意不依从相关(OR=2.27),习惯强度弱与无意不依从相关(OR=0.92)。
要点
- 自我给药系统治疗银屑病患者中22.4%报告不依从,其中有意不依从占12%。
- 口服传统系统药不依从率29.2%,高于依那西普或阿达木单抗的16.4%。
- 用药担忧最强组与有意不依从相关,习惯强度弱与无意不依从相关。
核心结论
- 银屑病系统治疗中自我报告不依从较常见,有意与无意不依从均存在。
- 用药信念(担忧)和服药习惯强度是可干预的依从性改善靶点。
研究设计与样本
- 采用自我报告评估不依从,并用多变量分析和潜在剖面分析心理与生物医学因素。
主要发现
- 使用口服传统系统药者不依从率29.2%,高于使用依那西普或阿达木单抗者的16.4%(P≤0.001)。
- 潜在剖面分析支持三组模型:第1组(26.4%)用药担忧最强,第2组(61%)次之,第3组(12.6%)最弱。
- 第1组与有意不依从相关(OR=2.27,95%CI=1.16-4.47)。
- 服药习惯强度较弱与无意不依从相关(OR=0.92,95%CI=0.89-0.96)。
临床怎么用
- 临床应识别患者用药担忧并针对性沟通,以减少有意不依从。
- 帮助患者建立规律服药习惯,可能减少无意不依从。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Medication non-adherence is a missed opportunity for therapeutic benefit. We assessed "real-world" levels of self-reported non-adherence to conventional and biologic systemic therapies used for psoriasis and evaluated psychological and biomedical factors associated with non-adherence using multivariable analyses. Latent profile analysis was used to investigate whether patients can be categorized into groups with similar medication beliefs. Latent profile analysis categorizes individuals with similar profiles on a set of continuous variables into discrete groups represented by a categorical latent variable. Eight hundred and eleven patients enrolled in the British Association of Dermatologists Biologic Interventions Register were included. Six hundred and seventeen patients were using a self-administered systemic therapy; 22.4% were classified as "non-adherent" (12% intentionally and 10.9% unintentionally). Patients using an oral conventional systemic agent were more likely to be non-adherent compared to those using etanercept or adalimumab (29.2% vs. 16.4%; P ≤ 0.001). Latent profile analysis supported a three-group model; all groups held strong beliefs about their need for systemic therapy but differed in levels of medication concerns. Group 1 (26.4% of the sample) reported the strongest concerns, followed by Group 2 (61%), with Group 3 (12.6%) reporting the weakest concerns. Group 1 membership was associated with intentional non-adherence (odds ratio = 2.27, 95% confidence interval = 1.16-4.47) and weaker medication-taking routine or habit strength was associated with unintentional non-adherence (odds ratio = 0.92, 95% confidence interval = 0.89-0.96). Medication beliefs and habit strength are modifiable targets for strategies to improve adherence in psoriasis.
引用
- Thorneloe RJ, Griffiths CEM, Emsley R, et al. Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients' Medication Beliefs and Habit Strength. J Invest Dermatol. 2017. PMID: 29183731. doi:10.1016/j.jid.2017.11.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。